FOXO TECHNOLOGIES INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $15.00K.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for the quarter ending 2023-12-31 was -$1.37K, a 100.14% decline year-over-year.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for the quarter ending 2023-09-30 was $0.00.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for the quarter ending 2023-06-30 was $2.47M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for fiscal 2025 was $3.28M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for fiscal 2023 was $2.47M, a 386.32% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. stock issued during period, value, other for fiscal 2022 was $507.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-03-31 | $15.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $3.28M 10-K · filed 2026-04-15 | |
| 2023-12-31 | -$1.37K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | $2.47M 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | |
| 2023-06-30 | $2.47M 10-Q · filed 2024-11-19 | |
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $507.00K 10-K · filed 2024-06-06 |
| 2022-09-30 | -$4.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |